Evidence map›Paper›PMID 35888137›Full record

ArticleLife (Basel, Switzerland)2022

In Vitro Skin Co-Delivery and Antibacterial Properties of Chitosan-Based Microparticles Containing Ascorbic Acid and Nicotinamide.

Leonardo Delello Di Filippo, Jonatas Lobato Duarte, Cesar Augusto Roque-Borda, Fernando Rogério Pavan, Andreia Bagliotti Meneguin, Marlus Chorilli, Ana Melero, Antonio José Guillot, Caroline Magnani Spagnol, Marcos Antônio Correa

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. ACS omega · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Pharmaceutical Biotechnology.Life (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Leonardo Delello Di FilippoSchool of Pharmaceutical Sciences, Sao Paulo State University "Julio de Mesquita Filho", Araraquara 14800903, SP, Brazil.ORCID 0000-0001-6365-8756
Jonatas Lobato DuarteSchool of Pharmaceutical Sciences, Sao Paulo State University "Julio de Mesquita Filho", Araraquara 14800903, SP, Brazil.
Cesar Augusto Roque-BordaSchool of Pharmaceutical Sciences, Sao Paulo State University "Julio de Mesquita Filho", Araraquara 14800903, SP, Brazil.ORCID 0000-0002-9262-0383
Fernando Rogério PavanSchool of Pharmaceutical Sciences, Sao Paulo State University "Julio de Mesquita Filho", Araraquara 14800903, SP, Brazil.
Andreia Bagliotti MeneguinSchool of Pharmaceutical Sciences, Sao Paulo State University "Julio de Mesquita Filho", Araraquara 14800903, SP, Brazil.
Marlus ChorilliSchool of Pharmaceutical Sciences, Sao Paulo State University "Julio de Mesquita Filho", Araraquara 14800903, SP, Brazil.ORCID 0000-0002-6698-0545
Ana MeleroPharmaceutical Technology and Parasitology, Department of Pharmacy, University of Valencia, 46010 Valencia, Spain.ORCID 0000-0003-0126-414X
Antonio José GuillotPharmaceutical Technology and Parasitology, Department of Pharmacy, University of Valencia, 46010 Valencia, Spain.ORCID 0000-0001-8012-326X
Caroline Magnani SpagnolSchool of Pharmaceutical Sciences, Sao Paulo State University "Julio de Mesquita Filho", Araraquara 14800903, SP, Brazil.ORCID 0000-0002-1329-8251
Marcos Antônio CorreaSchool of Pharmaceutical Sciences, Sao Paulo State University "Julio de Mesquita Filho", Araraquara 14800903, SP, Brazil.
Universidade Estadual Paulista (Unesp) · BRUniversitat de València · ES

Funding

São Paulo Research Foundation 2015/19097-0, 2016/20957-6, 2015/02619-3, 2020/16573-3, 2019/25125-7.University of Valencia UV-19-INV-AE19
6 · The paper itself

Abstract

Vitamins are widely found in nature, for example, in plants and fruits. Ascorbic acid and nicotinamide are examples of these compounds that have potent antioxidant properties, besides stimulating collagen production and depigmenting properties that protect the skin from premature aging. To overcome the skin barrier and reduce the instability of antioxidant compounds, alternative systems have been developed to facilitate the delivery of antioxidants, making them efficiently available to the tissue for an extended time without causing damage or toxicity. The objective of this study was to obtain chitosan biodegradable microparticles containing ascorbic acid and nicotinamide for topical delivery. The microparticles were obtained by spray drying and characterized chemically by means of scanning electron microscopy, infrared spectroscopy, X-ray diffraction, and differential exploratory calorimetry. The drugs were successfully encapsulated and the microparticles showed positive zeta potential. In vitro release assays showed a sustained release profile. The evaluation of ex vivo skin permeation and retention demonstrated low permeation and adequate retention of the compounds in the epidermis/dermis, suggesting the efficient delivery from the obtained microparticles. Antibacterial assays have shown that microparticles can inhibit the growth of microorganisms in a time- and dose-dependent manner, corroborating their use in cosmetic products for application on the skin.

Indexed as

antioxidantspolymeric microparticlesskin deliveryspray drying

Identifiers

PMID35888137
PMCPMC9319839
OpenAlexW4285390208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.